BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 309 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $544,000 | -0.9% | 3,950 | 0.0% | 0.18% | -8.5% |
Q3 2021 | $549,000 | +7.6% | 3,950 | -24.8% | 0.20% | +6.4% |
Q2 2021 | $510,000 | +2.8% | 5,250 | -27.6% | 0.19% | -3.6% |
Q1 2021 | $496,000 | -1.0% | 7,250 | +23.9% | 0.20% | -9.7% |
Q4 2020 | $501,000 | +31.8% | 5,850 | 0.0% | 0.22% | +16.1% |
Q3 2020 | $380,000 | +118.4% | 5,850 | -57.5% | 0.19% | +104.4% |
Q2 2020 | $174,000 | – | 13,750 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |